Protocol of a Randomised, Single Blind, Placebo-controlled RESCAP Intervention Study to Determine the Safety of RESCAP in Diabetes: RAPID Protocol – Rationale and Design

Código QR

Protocol of a Randomised, Single Blind, Placebo-controlled RESCAP Intervention Study to Determine the Safety of RESCAP in Diabetes: RAPID Protocol – Rationale and Design

Guardado en:

Detalles Bibliográficos
Autores principales:	V Popov, R Brands, N Bulanova
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/fd4e8fdf8a0b4c4794da759ec2183a0b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Investigating the efficacy of chest pressure for direct current cardioversion in atrial fibrillation: a randomised control trial protocol (Pressure-AF)
por: David Ferreira, et al.
Publicado: (2021)

Clinical analysis of cardiac autonomic ganglion plexus ablation for bradyarrhythmia: Research protocol for an intervention study
por: Mingliang Shao, et al.
Publicado: (2021)

A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol
por: M Matsuda, et al.
Publicado: (2020)

Cardiogenic Shock: Protocols, Teams, Centers, and Networks
por: Alex F Warren, et al.
Publicado: (2021)

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
por: Nicholas K Brownell, et al.
Publicado: (2021)

Hypotensive Action of Melatonin in Patients with Arterial Hypertension
por: E Ahsanova, et al.
Publicado: (2020)

Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study
por: Dunbar Ivy, et al.
Publicado: (2021)

Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project
por: Ricardo Lopez Santi, et al.
Publicado: (2021)

Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
por: Mauro Gori, et al.
Publicado: (2021)

Safety and Effectiveness of Coronary Angiography or Intervention through the Distal Radial Access: A Meta-Analysis
por: Jun Cao, et al.
Publicado: (2021)

Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
por: James L Januzzi, et al.
Publicado: (2021)

Dynamic High-density Functional Substrate Mapping Improves Outcomes in Ischaemic Ventricular Tachycardia Ablation: Sense Protocol Functional Substrate Mapping and Other Functional Mapping Techniques
por: Nikolaos Papageorgiou, et al.
Publicado: (2021)

Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2019)

Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2020)

Flight safety in patients with arrhythmia
por: Fahrettin Katkat
Publicado: (2021)

Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study
por: Michael C. Wang, et al.
Publicado: (2021)

Calcified Lesion Assessment and Intervention in Complex Percutaneous Coronary Intervention: Overview of Angioplasty, Atherectomy, and Lithotripsy
por: Alexander G Truesdell, et al.
Publicado: (2020)

Coronavirus disease 2019 and flight safety
por: Sevgi Özcan
Publicado: (2021)

Unsolved issues of The Efficacy and Safety of Edoxaban
por: Leszek Drabik, et al.
Publicado: (2021)

Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings
por: Johan Ärnlöv, et al.
Publicado: (2021)

Percutaneous Coronary Intervention for Chronic Total Occlusion
por: Giovanni Maria Vescovo, et al.
Publicado: (2020)

State-of-the-art Structural Interventions in Heart Failure
por: Jeffrey Park, et al.
Publicado: (2019)

Antithrombotic Therapy in Chronic Total Occlusion Interventions
por: Iosif Xenogiannis, et al.
Publicado: (2021)

Timing of Intervention in Asymptomatic Patients with Aortic Stenosis
por: Teresa Sevilla, et al.
Publicado: (2021)

Transcatheter Tricuspid Valve Intervention: Current Perspective
por: Trevor J Simard, et al.
Publicado: (2021)

Post percutaneous coronary intervention hemoglobin levels predict in-hospital mortality in patients with STEMI treated with primary percutaneous coronary intervention
por: Gönül Zeren, et al.
Publicado: (2021)

Evaluating the Potential Effect of L-carnitine on the Prevention of AF Following Coronary Artery Bypass Graft Surgery: A Randomised Clinical Trial
por: F Dastan
Publicado: (2020)

Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial
por: Yutao Guo, et al.
Publicado: (2020)

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
por: Zoltán Papp, et al.
Publicado: (2020)

Strategies to Reduce Radiation Exposure in Electrophysiology and Interventional Cardiology
por: Sandeep Shankar, et al.
Publicado: (2020)

Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
por: Tamara García Camarero, et al.
Publicado: (2020)

Percutaneous Coronary Intervention: Developments in the Last 12 Months
por: Rhian E Davies, et al.
Publicado: (2019)

Role of Intravascular Ultrasound in Guiding Complex Percutaneous Coronary Interventions
por: Brandon Quintana, et al.
Publicado: (2020)

The Role of Hemodynamic Support in High-risk Percutaneous Coronary Intervention
por: Charles Simonton, et al.
Publicado: (2020)

Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
por: Despoina-Rafailia Benetou, et al.
Publicado: (2021)

GLP-1, SGLT-2, new devices for interventional cardiologists
por: Çetin Erol
Publicado: (2021)

Feasibility, Safety, and Clinical Performance of Self-apposing Stents for Left Main Stenosis
por: Krzysztof Pujdak, et al.
Publicado: (2020)

Catheter Interventions for Acute Deep Venous Thrombosis: Who, When and How
por: Catherine Go, et al.
Publicado: (2020)

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
por: Gianluigi Savarese
Publicado: (2019)

Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
por: Dimitrios Alexopoulos, et al.
Publicado: (2020)